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Abstract
Aims/hypothesis We aimed to examine the association be-
tween breast-feeding and maternal risk of type 2 diabetes
and to investigate whether this association is mediated by
anthropometric and biochemical factors.
Methods A case–cohort study nested within the European
Prospective Investigation into Cancer and Nutrition
(EPIC)-Potsdam Study between 1994 and 2005 including
1,262 childbearing women (1,059 in a random sub-cohort
and 203 incident cases) mainly aged between 35 and
64 years at baseline was applied. Self-reported lifetime
duration of breast-feeding was assessed by questionnaire.
Blood samples were used for biomarker measurement
(HDL-cholesterol, triacylglycerols, C-reactive protein,
fetuin-A, γ-glutamyltransferase, adiponectin). A systematic
literature search and meta-analysis was conducted of pro-
spective cohort studies investigating breast-feeding and
risk of type 2 diabetes.
Results The HR for each additional 6 months of breast-
feeding was 0.73 (95% CI 0.56, 0.94) in EPIC-Potsdam.
Meta-analysis of three previous prospective studies and the
current study revealed an inverse association between breast-
feeding duration and risk of diabetes (pooled HR for lifetime
breast-feeding duration of 6–11 months compared with no
breast-feeding 0.89; 95% CI 0.82, 0.97). Adjustment for
BMI and waist circumference attenuated the association (HR
per six additional months in EPIC-Potsdam 0.80; 95% CI 0.61,
1.04). Further controlling for potentially mediating biomarkers
largely explained this association (HR 0.89; 95% CI 0.68, 1.16).
Conclusions/interpretation Longer duration of breast-feeding
may be related to a lower risk of diabetes. This potentially
protective effect seems to be reflected by a more favourable
metabolic profile; however, the role of body weight as a
mediator or confounder remains uncertain.
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Positive effects of breast-feeding have mostly been attributed
to the health of the child [1]. Other findings suggest that
mothers can benefit from breast-feeding as well [2, 3].
Although three prospective studies observed an inverse asso-
ciation between prolonged breast-feeding and the incidence of
type 2 diabetes [4, 5], data are still scarce, and the underlying
mechanisms by which breast-feeding lowers diabetes risk
remain unclear. During gestation, enormous changes occur
in women’s metabolism to ensure sufficient supply to the
fetus. Breast-feeding is thought to ‘reset’ these metabolic
changes [6]. Exclusive breast-feeding is accompanied by an
increased energy requirement of about 2,000 kJ/day [7], but
the impact of breast-feeding on longer-term weight develop-
ment post partum remains unclear [8–10]. Studies also suggest
higher insulin sensitivity and glucose tolerance in breast-
feeding women [7, 9]. Although these observations contribute
to the hypothesis that breast-feeding reduces the risk of type 2
diabetes, systematic evaluation of different pathways is so far
lacking.
Our aims were therefore threefold: first, we evaluated the
association between breast-feeding and diabetes risk in a large
prospective study; second, we systematically reviewed other
prospective studies evaluating this hypothesis; third, we in-
vestigated possible mechanisms underlying the association
between breast-feeding and maternal risk of type 2 diabetes
by evaluating a large set of diabetes-related markers reflecting
insulin sensitivity or lipid metabolism as well as markers of
liver fat accumulation and inflammation.
Methods
Study population The European Prospective Investigation in-
to Cancer and Nutrition (EPIC)-Potsdam Study has 27,548
participants (16,644 women and 10,904 men). The recruit-
ment took place between 1994 and 1998 and focused on the
general population in Potsdam and the surrounding area. All
participants provided informed consent, and permission was
given by the ethics committee of the State of Brandenburg,
Germany. The baseline examination involved a personal
interview including questions on prevalent diseases and
women’s health, a self-administered questionnaire about
socioeconomic and lifestyle characteristics and number
of births including breast-feeding, interviewer-conducted
anthropometric measurements and blood sample collec-
tion [11]. We used a case–cohort design (electronic
supplementary material [ESM] Fig. 1) to evaluate bio-
chemical risk factors for diabetes, described in detail
previously [12]. From 26,444 participants who provided
blood samples at baseline, 2,500 individuals were ran-
domly selected. Of 1,430 women within this random
sub-cohort, 1,301 reported having given birth. We ex-
cluded women with missing data on breast-feeding be-
haviour (n=17), missing data on oral contraceptive use,
implausible energy intake (<3,349 or >25,121 kJ/day)
and prevalent diabetes including gestational diabetes
mellitus (GDM), as well as women with missing data
on BMI at the age of 25 years and missing biomarker
measurements, leaving 1,059 women for analysis in the
sub-cohort. After application of similar exclusion
criteria, 226 incident cases identified among all child-
bearing mothers in the cohort remained for analysis
(overlap of 23 women with the sub-cohort due to the
case–cohort design).
Assessment of breast-feeding duration and covariates
ESM Fig. 2 illustrates the time points of data collection and
exposures.
Women recalled their age at childbirth and whether and for
how long they breast-fed their children, separately for their
first, second, third and last child (women with more than three
children) in a self-administered questionnaire at the baseline
examination. Eleven categories were given: 1 week or less;
2–3 weeks; 4–5 weeks; 6–7 weeks; 2 months; 3 months; 4–5
months; 6–7 months; 8–9 months; 10–11 months; 12 months
or more.
Age at baseline examination and socioeconomic and life-
style factors such as marital status, level of education, occu-
pation, smoking behaviour and physical activity were
assessed by a self-administered questionnaire and a personal
interview. Weight, height and waist circumference at baseline
examination were measured by trained interviewers who
followed standard protocols under strict quality control. BMI
at the age of 25 years was calculated from body weight at the
age of 25 years (self-reported at baseline) and measured
height. Dietary intake during the preceding 12 months was
assessed through a validated food frequency questionnaire.
Determination of biomarkers We used a large set of bio-
markers reflecting insulin sensitivity and lipid metabolism as
well as markers of liver fat accumulation, such as
γ-glutamyltransferase and fetuin-A, and C-reactive protein
(CRP) as an inflammation-related marker.
Biomarkers were measured in blood samples collected at
the baseline examination and stored at −80°C or lower until
analysis. Plasma CRP concentrations were measured with a
high-sensitivity latex-enhanced immunoturbidimetric assay
on an automatic Advia 1650 Analyzer (Siemens Medical
Solutions, Erlangen, Germany). Plasma adiponectin concen-
trations were determined by ELISA (Linco Research, St
Charles, MO, USA). Plasma levels of triacylglycerols, HDL-
cholesterol, γ-glutamyltransferase and fetuin-A were mea-
sured with the automatic Advia 1650 Analyzer. For determi-
nation of fetuin-A, an immunoturbidimetric method was used
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with specific polyclonal goat antibodies to human fetuin-A
(BioVendor Laboratory Medicine, Modreci, Czech Republic)
[12]. All assay procedures were performed according to the
manufacturer’s description. LDL-cholesterol levels were cal-
culated using the Friedewald equation [13].
Assessment of type 2 diabetes Every 2–3 years, follow-up
questionnaires were sent out to identify incident cases of
diabetes. All incident cases were verified by treating physi-
cians, who were asked in a questionnaire to provide data on
the date and type of diagnosis, diagnostic tests and the treat-
ment. Cases confirmed by a physician (ICD-10: E11) and a
diagnosis date after the baseline examination were considered
to be confirmed incident cases of type 2 diabetes. For the
present analysis, we used data collected until August 2005.
Women with missing follow-up questionnaires were excluded
from the analysis. However, the follow-up rate was high,
exceeding 95%, and was similar between breast-feeding cat-
egories (data not shown).
Statistical analysis Lifetime breast-feeding duration was cal-
culated as the sum of breast-feeding periods for each child and
was stratified into five categories: no breast-feeding; ≤3weeks;
>3 weeks to <2 months; ≥2 months to <6 months; ≥6 months.
To evaluate the association between single biomarkers and
breast-feeding duration as a continuous variable (per addition-
al 6 months), we used multivariate linear regression models.
Biomarkers were not normally distributed after log-
transformation, therefore Box–Cox transformation was used.
Associations between breast-feeding and diabetes risk were
evaluated using Cox regression modified for the case–cohort
design according to the Prentice method [14]. The proportion-
al hazards assumption was tested by plotting the Schönfeld
residuals [15]. Age was used as the primary time-dependent
variable in all models, with entry time defined as the partici-
pant’s age at recruitment, and exit time as the date of diagno-
sis, death or return of the last follow-up questionnaire. Cox
models were stratified for age at baseline and further adjusted
for marital status (unmarried, married, divorced, widowed),
education (no vocational training or in training, vocational
training, technical school, technical college or university),
occupation (sedentary, standing, or [heavy] manual work),
smoking behaviour (never smoker, ex-smoker, current smoker
<20 units/day, current smoker ≥20 units/day), sporting activ-
ities (no sport, ≤4 h/week, >4 h/week), biking (no biking,
<2.5 h/week, 2.5–4.9 h/week, ≥5 h/week), alcohol intake
(no alcohol intake, 0 to ≤5 g/day, >5 to ≤10 g/day,
>10 to ≤20 g/day, >20 to ≤40 g/day, >40 g/day), coffee
consumption (ml/day), intake of red meat (g/day), intake
of whole-grain bread (g/day), age at birth of last child,
number of children, duration of oral contraceptive use
(no use, ≤5 years, 6–10 years, >10 years), as well as
BMI at the age of 25 years, baseline BMI and waist
circumference. To evaluate potential biochemical media-
tors, we adjusted for different biomarkers determined in
blood samples collected at baseline. Attenuation of the
association indicates a mediator effect. We conducted
several sensitivity analyses. We thereby stratified the
analysis for number of children, educational level of
the mothers, and time since last birth. Stratification for
the age at first birth with a cut-off of 25 years was used
to evaluate if BMI in young adulthood acts as both a
confounder and a mediator. All data analyses were
performed using the software package SAS Enterprise
Guide 4.3 (SAS Institute, Cary, NC, USA).
Meta-analysis We searched the PubMed and Web of Science
databases for published studies on the association between
breast-feeding and maternal risk of type 2 diabetes. A total of
300 references were identified from the two databases by
combining text words and medical subject heading (MESH)
terms in PubMed (the search strategy in the ESM Methods
and the flow diagram in ESM Fig. 3). Eight additional refer-
ences were identified by the Web of Science ‘Times cited’
function. The search was completed on 27 March 2014.
Reference lists of retrieved studies provided no additional
articles. Our inclusion criteria were: prospective cohort study;
type 2 diabetes as outcome; description of breast-feeding as-
sessment; presentation of relative risks with 95% CI; descrip-
tion of adjustment for potential confounders. We excluded
animal studies and human studies that focused on children’s
health or other outcomes such as weight change, metabolic
changes, cardiovascular diseases or GDM. Unpublished mate-
rial was not considered. The literature review was performed
by two authors (S. Jäger, S. Jacobs), and data were extracted
for multivariate-adjusted models (with and without adjustment
for BMI). To evaluate the quality of the included studies, we
adapted a score derived from Hu et al [16], which summarizes
14 aspects of each study (ESM Table 1). Meta-analysis was
performed with small Stata, version 12.0 (Stata Corp, College
Station, TX, USA) using fixed-effects models. Degree of het-
erogeneity was expressed as an I2 statistic, and Cochran’s Q
test of heterogeneity (α=0.05) was performed [17]. We
assessed potential publication bias by regressing the standard
normal deviate (HR/SE) against precision (1/SE) with α=0.1
[18].
Results
Table 1 shows baseline characteristics of the sub-cohort by
cumulative duration of breast-feeding.Womenwho breast-fed
longer tended to be older and were more likely to be married
and better educated. Longer duration of breast-feeding was
associated with less smoking and higher physical activity, but
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Table 1 Baseline characteristics of parous women by duration of breast-feeding in EPIC-Potsdam
Characteristic Cumulative duration of breast-feeding p valuea





n 159 148 184 304 264
Age at baseline, median (IQR) 47.0 (15.0) 46.0 (15.0) 47.0 (16.5) 47.0 (17.0) 49.0 (19.0) 0.4612
Marital status, % 0.3981
Unmarried 6.92 5.41 4.35 2.30 3.41
Married 71.1 74.3 77.2 76.6 80.3
Divorced 17.6 16.2 13.6 16.8 14.4
Widowed 4.40 4.05 4.89 4.28 1.89
Education, % 0.0148
No vocational training or in training 4.40 2.03 4.89 3.62 6.82
Vocational training 41.5 44.6 37.5 35.2 31.8
Technical school 28.3 33.8 28.3 32.6 25.0
Technical college, university 25.8 19.6 29.4 28.6 36.4
Occupation, % 0.1177
Sedentary occupation 65.4 68.9 55.4 63.8 61.7
Standing occupation and (heavy) manual work 34.6 31.1 44.6 36.2 38.3
Smoking, % 0.1801
Never smoker 54.7 54.1 57.6 60.5 61.4
Ex-smoker 25.2 27.0 25.0 20.7 24.2
Smoker <20 units/day 13.8 14.2 16.9 15.8 11.7
Smoker ≥20 units/day 6.29 4.73 0.54 2.96 2.65
Physical activity (h/week), median (IQR)b 2.00 (4.00) 1.50 (3.50) 1.50 (3.50) 2.00 (3.50) 2.50 (4.25) 0.0970
Coffee consumption (ml/day), median (IQR) 300 (450) 450 (300) 300 (300) 300 (300) 300 (450) 0.0846
Red meat intake (g/day), median (IQR) 27.4 (27.8) 30.3 (23.2) 33.7 (24.3) 31.3 (26.1) 31.6 (25.2) 0.6453
Whole-grain bread intake (g/day), median (IQR) 30.3 (62.4) 25.7 (61.6) 32.3 (62.1) 29.8 (65.2) 36.9 (62.0) 0.2935
Alcohol (g/day), median (IQR) 5.07 (8.66) 5.36 (10.6) 5.25 (7.82) 5.19 (7.87) 5.02 (8.67) 0.9801
Age at birth of first child, median (IQR) 23.0 (5.00) 23.0 (4.50) 23.0 (4.00) 23.0 (4.00) 23.0 (5.00) 0.0813
Age at birth of last child, mean (SD) 26.6 (5.03) 25.9 (4.12) 26.2 (4.14) 26.9 (4.24) 28.2 (4.14) <0.0001
Number of children, median (IQR) 1 (1) 2 (1) 2 (1) 2 (1) 2 (1) <0.0001
Breast-feeding duration per child in months, median (IQR) 0.28 (0.38) 0.81 (0.50) 1.81 (0.97) 4.71 (3.08) <0.0001
Use of oral contraceptives, % <0.0001
No use 18.9 12.2 10.9 15.1 17.1
≤5 years 13.8 14.2 16.9 15.8 28.4
>5 and ≤10 years 12.0 16.9 18.5 17.1 20.1
>10 years 55.4 56.8 53.8 52.0 34.5
BMI at age of 25 years (kg/m2), median (IQR) 22.3 (3.28) 21.6 (3.06) 22.1 (2.97) 21.4 (3.04) 21.6 (3.40) 0.0032
BMI at baseline (kg/m2), median (IQR) 25.8 (6.56) 24.2 (4.98) 24.9 (5.67) 24.3 (5.25) 24.6 (5.80) 0.0056
Waist circumference (cm), median (IQR) 80.0 (17.0) 78.0 (14.5) 78.3 (16.0) 77.5 (13.8) 79.0 (16.0) 0.0168
Triacylglycerols (mmol/l), median (IQR) 1.20 (0.92) 1.02 (0.59) 1.03 (0.70) 1.09 (0.68) 1.01 (0.62) 0.0060
HDL-cholesterol (mmol/l), mean (SD) 1.52 (0.37) 1.51 (0.39) 1.52 (0.37) 1.57 (0.39) 1.57 (0.37) 0.2561
LDL-cholesterol (mmol/l), mean (SD) 3.00 (0.96) 2.90 (0.79) 2.95 (0.87) 3.06 (0.85) 3.11 (0.95) 0.2215
CRP (nmol/l), median (IQR) 9.90 (25.4) 7.71 (26.0) 9.90 (28.8) 7.71 (18.8) 6.67 (14.4) 0.0697
Fetuin-A (μg/ml), mean (SD) 268 (62.4) 268 (64.9) 274 (60.4) 267 (62.4) 265 (64.6) 0.6200
GGT (μkat/l), median (IQR) 0.23 (0.23) 0.23 (0.20) 0.21 (0.19) 0.21 (0.17) 0.19 (0.20) 0.2433
Adiponectin (μg/ml), median (IQR) 8.52 (5.81) 9.29 (5.20) 9.42 (5.77) 8.93 (5.52) 9.43 (4.78) 0.1943
IQR, interquartile range; GGT, γ-glutamyltransferase
a χ2 tests (for categorical variables), ANOVA tests (for normally distributed variables), or Kruskal–Wallis tests (for not normally distributed variables.
Variables were log-transformed if this resulted in normal distributions)
b Sum of biking and sporting activities in h/week
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occupation and nutritional factors showed no association.
Longer duration of breast-feeding was also related to a greater
age at birth of the last child, a larger number of children,
longer duration of breast-feeding per child, and lower use of
oral contraceptive. Women who had never breast-fed had
higher BMI and waist circumference levels at the baseline
examination compared with women who had. The biomarkers
showed no major differences across breast-feeding categories
at baseline. Baseline characteristics of the sub-cohort (with
and without internal cases) and all incident type 2 diabetes
cases are provided in ESM Table 2.
We used multivariate linear regression models to eval-
uate the covariate-adjusted associations between different
biomarkers and cumulative duration of breast-feeding
(ESM Table 3). No single biomarker was strongly associ-
ated with breast-feeding duration. However, we observed
an inverse relation between breast-feeding duration and
triacylglycerols, which became non-significant after adjust-
ment for anthropometry. In contrast, HDL-cholesterol and
adiponectin were positively associated.
Table 2 presents associations between duration of breast-
feeding and risk of type 2 diabetes. In age-adjusted models,
mothers who had ever breast-fed had a lower risk of type 2
diabetes than mothers who had never breast-fed (HR 0.62;
95% CI 0.43, 0.88). This inverse association was also observ-
able when different durations of breast-feeding were evaluated,
with women who had breast-fed for ≥6 months having the
lowest risk compared with women who had never breast-fed
(HR 0.46; 95% CI 0.29, 0.73). Adjustment for lifestyle and
other reproductive factors strengthened these associations (HR
0.31 [95% CI 0.18, 0.55] for women who had breast-fed for
≥6 months compared with those who had never breast-fed).
While the lower risk in women who had ever breast-fed
compared with women who had never breast-fed remained
after BMI at the age of 25 years had been accounted for (HR
0.59; 95% CI 0.39, 0.89), adjustment for BMI and waist
circumference at baseline moderately attenuated the associa-
tion, which became—although still inverse—non-significant
(HR 0.77; 95% CI 0.47, 1.25). Similarly, a longer duration of
breast-feeding remained associated with a decreased risk of
type 2 diabetes after anthropometric characteristics had been
accounted for (HR per 6 months 0.80; 95% CI 0.61, 1.04).
Women who had breast-fed for 6 months or longer had an HR
of 0.47 (95% CI 0.25, 0.89) compared with women who had
never breast-fed.
In sensitivity analysis (ESM Table 4), we stratified the data
by number of children. Mothers with one child had a
confounder-adjusted HR per 6 months of 0.83 (95% CI 0.39,
1.76), with two children they had an HR of 0.77 (95% CI 0.52,
1.15), and with three children the HR was 0.72 (95% CI 0.43,
1.19). We further analysed substrata according to the time lap
between last birth and baseline examination (ESM Table 4).
The inverse association between breast-feeding and diabetes
appeared to be slightly stronger among women who gave birth
less than 20 years before baseline (HR per 6 months 0.67; 95%
CI 0.31, 1.46) than amongwomenwho gave birth to their latest
child 20 years or longer before baseline (HR 0.73; 95% CI
0.55, 0.97).
To investigate the role of body mass in early adulthood as a
potential confounder vs mediator, we used BMI at age 25 as a
proxy measure and stratified the analysis by the age at which
women had given birth to their first child (considering an age
of either ≤24 or ≥26 to define subgroups) (ESM Table 4).
Breast-feeding was associated with lower diabetes risk irre-
spective of the age at first birth, and adjustment for self-
reported BMI at age 25 had no appreciable effect on the
strength of association in both strata. In analysis stratified by
education, an important confounding factor, we observed no
major difference when evaluating breast-feeding categories
(ESM Table 4). The HR for duration of breast-feeding per
6 months in women without a university degree was 0.68
(95% CI 0.50, 0.91), while there was no association observ-
able among women with a university degree (HR 0.94; 95%
CI 0.59, 1.51).
Meta-analysis We conducted a meta-analysis of prospective
studies on breast-feeding and diabetes risk. In addition to our
study, we were able to identify two previous publications [4, 5],
with one article involving two different cohort studies [4]
(Table 3). The cohorts included 220,360 mothers from the
USA, China and Germany, involving 8,064 incident cases of
type 2 diabetes. All studies used self-reported breast-feeding
data. However, different breast-feeding categories were de-
fined. We pooled confounder-adjusted data from our cohort
and the Nurses’ Health cohorts reported by Stuebe et al [4] in
most analyses. The Shanghai Women’s Health cohort [5] was
only used for evaluating long duration of breast-feeding
(>6–11 months) in comparison with never breast-feeding.
However, these data were not adjusted for number of live
births. As Fig. 1 indicates, all studies observed inverse associ-
ations between breast-feeding and risk of type 2 diabetes.
Womenwho had ever breast-fed were at lower risk thanwomen
who had never breast-fed (summary HR 0.95; 95% CI 0.90,
1.00). However, there was significant heterogeneity in the
results (I2=74.3%, p=0.020). The pooled HR was 0.89 (95%
CI 0.82, 0.97) for women who had breast-fed for 6–11 months
compared with mothers who had never breast-fed (I2=68.0%,
p=0.025). Per additional year of breast-feeding, the pooled
HR was 0.93 (95% CI 0.90, 0.96) with high heterogeneity
(I2=88.1%, p<0.001). The Egger test provided evidence of
publication bias for two categories of breast-feeding dura-
tion (>6–11 months, p=0.022; >11–23 months, p=0.009).
In a supplemental analysis, we pooled models with adjust-
ment for baseline BMI. While adjustment for BMI had only a
marginal effect on the strength of association, associations
were mainly not statistically significant (ESM Fig. 4).
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Analysis of biochemical mediators
Further adjustment for biomarkers (Table 4) attenuated the
association, with the strongest attenuation observed with ad-
justment for lipid biomarkers (HR per 6 months 0.85; 95% CI
0.66, 1.09) and adiponectin (HR 0.84; 95% CI 0.64, 1.10).
Accounting for all biomarkers simultaneously in one model
largely attenuated the association (HR per 6months 0.89; 95%
CI 0.68, 1.16; HR for ever vs never breast-fed 0.95; 95% CI
0.59, 1.53).
Discussion
In the present study, breast-feeding was associated with a
lower risk of type 2 diabetes. This association was indepen-
dent of potential confounding sociodemographic, lifestyle and
reproductive risk factors. Furthermore, meta-analysis of co-
hort studies indicated an inverse association. Adjustment for
BMI at baseline had little effect on this relationship, while
accounting for an at-risk metabolic profile in adult life,
reflected by several biomarkers, largely explained the associ-
ation between breast-feeding and type 2 diabetes.
A systematic literature search and meta-analysis including
results from EPIC-Potsdam as well as findings from previous
prospective cohort studies [4, 5] suggest that longer breast-
feeding duration may be associated with a lower risk of type 2
diabetes. Included studies showed good quality characterised
by their prospective design, a comparable breast-feeding as-
sessment, detailed adjustment sets and low rates of loss to
follow-up (ESM Table 1). However, there was high heteroge-
neity between the studies, which complicates the drawing of
general conclusions. The women in these four cohorts showed
quite different breast-feeding patterns. German women breast-
fed for a comparatively short time. Further limitations come
from the imprecision of assessing breast-feeding behaviour on
the basis of self-reports. Some studies found good validity of
self-reported breast-feeding history after more than 20 years
compared with medical records [19, 20]. Others criticise the
retrospective collection of breast-feeding data via question-
naires [21]. Factors such as socioeconomic status and the
number of children could affect the mother's memory
[22–24]. Furthermore, breast-feeding was self-reported, irre-
spective of additional feeding, and therefore was not stratified
as exclusive or non-exclusive breast-feeding, which may be of
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Fig. 1 HRs (95% CIs) for
association between duration of
breast-feeding and type 2
diabetes. Categories of breast-
feeding duration (compared with
no breast-feeding): breast-feeding
vs non-breast-feeding (a), >0 to
3 months (b), >3 to 6 months (c),
>6 to 11 months (d), >11 to
23 months (e), per additional year
(f). Models are adjusted for
potential confounders. NHS,
Nurses’ Health Study; SWHS,
Shanghai Women’s Health Study
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We cannot exclude residual confounding. Breast-feeding is
highly related to sociodemographic factors. Adjusting for
marital status, educational level and occupation and stratifica-
tion for educational level had no influence on the association
in our study. However, we cannot rule out the possibility that
other correlates of breast-feeding, e.g. related to income, could
explain our observation.
In addition, there is the possibility that cases remained
undiagnosed during follow-up and were therefore
misclassified as false-negative. However, this misclassifica-
tion should not bias the associations given that false-positive
case definitions should have been rare in most cohorts because
of the verification procedures (EPIC-Potsdam) or the high
accuracy of self-reports among nurses (US cohorts) [26].
Finally, the Egger test provided evidence of publication
bias. We addressed this observation by using fixed-effects
models in the meta-analysis [27]. However, only a few studies
were available for this meta-analysis, and exclusion of one
study that contributed the lowest weight but showed the
strongest associations did not alter the overall result of the
meta-analysis (data not shown).
The underlyingmechanisms bywhich breast-feeding could
lower diabetes risk are still unknown, although several hy-
potheses of dependence on weight development and metabol-
ic pathways have been suggested.
High prepregnancy BMI and extreme weight gain during
pregnancy have been associated with early termination of
breast-feeding [28, 29]. Therefore, a shorter duration of
breast-feeding may be a consequence, rather than a cause, of
increased body weight, supporting the hypothesis that BMI
acts as a confounder. However, other studies suggest that
weight changes may mediate the association between breast-
feeding and incident type 2 diabetes [6]. Breast-feeding is
associatedwith higher energy requirements [7]. These require-
ments are compensated for by a higher energy intake and less
physical activity during the first 3 months after delivery. Later
on, women begin to mobilise fat stores accumulated through
pregnancy [30, 31]. During breast-feeding periods, signifi-
cantly higher lipolysis in the femoral region has been observed
[32]. Therefore femoral adipose tissue acts as an important
source of energy during lactation. Previous studies have ob-
tained controversial results on the importance of weight
change. Butte and Hopkinson [8] reviewed 17 prospective
studies conducted in industrialised and developing countries.
Most studies demonstrated no difference in weight change
between breast-feeding and non-breast-feeding women.
However, participants were only followed-up for up to
6 months post partum. While some studies support these
findings [33], others found breast-feeding to be associated
with lower post partumweight retention [10, 34]. In our study,
adjusting for self-reported BMI at the age of 25 showed only a
slight effect on the relationship. Although adjustment for BMI
and waist circumference assessed at baseline had stronger
attenuating effects, an inverse association between breast-
feeding and diabetes remained, especially in the longest-
duration breast-feeding category. It can be discussed whether
BMI assessed many years after breast-feeding acts as a con-
founder or a mediator in this context. Although less weight gain
with breast-feeding is a plausible mediator, BMI at baseline
may also partly reflect prepregnancy weight status or other
Table 4 HRs (95% CI) for type 2 diabetes by duration of breast-feeding with adjustment for biochemical mediators, EPIC-Potsdam study
Ever breast-fed Cumulative duration of breast-feeding




≥6 months Per additional
6 months
of breast-feeding
n cases 49 177 49 31 38 66 42 226
Model I 1 0.77 (0.47, 1.25) 1 1.16 (0.62, 2.19) 0.77 (0.43, 1.41) 0.82 (0.47, 1.41) 0.47 (0.25, 0.89) 0.80 (0.61, 1.04)
Model I + HDL, LDL,
triacylglycerols
1 0.88 (0.55, 1.42) 1 1.38 (0.71, 2.69) 0.93 (0.51, 1.67) 0.91 (0.53, 1.57) 0.55 (0.29, 1.02) 0.85 (0.66, 1.09)
Model I + CRP 1 0.73 (0.45, 1.18) 1 1.11 (0.59, 2.08) 0.72 (0.39, 1.32) 0.77 (0.45, 1.33) 0.47 (0.25, 0.88) 0.81 (0.62, 1.06)
Model I + fetuin-A, GGT 1 0.78 (0.48, 1.26) 1 1.24 (0.66, 2.33) 0.78 (0.43, 1.42) 0.83 (0.48, 1.42) 0.47 (0.24, 0.90) 0.81 (0.62, 1.06)
Model I + adiponectin 1 0.91 (0.57, 1.45) 1 1.64 (0.90, 3.00) 0.91 (0.51, 1.64) 0.93 (0.54, 1.59) 0.58 (0.31, 1.07) 0.84 (0.64, 1.10)
Model I + HDL, LDL,
triacylglycerols +
CRP + fetuin-A, GGT +
adiponectin
1 0.95 (0.59, 1.53) 1 1.74 (0.91, 3.32) 1.00 (0.55, 1.83) 0.91 (0.53, 1.58) 0.62 (0.33, 1.16) 0.89 (0.68, 1.16)
GGT, γ-glutamyltransferase
Model I adjusted for age at baseline, marital status, education, occupation, smoking, sport, cycling, alcohol intake, coffee consumption, intake of red
meat, intake of whole-grain bread, age at birth of last child, number of children, duration of oral contraceptive use, BMI at age of 25 years, BMI andwaist
circumference at baseline examination. n=1,262
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confounding factors associated with body fatness and which
may have insufficiently been controlled for by using lifestyle
confounders and retrospectively self-reported BMI at age 25.
While adjustment for biomarkers revealed an attenuation of
results in our analysis, another cohort study found no clear
dose–response associations between breast-feeding and ma-
ternal glucose and lipid metabolism or inflammatory markers
3 years post partum [35].
Still, prolonged breast-feeding seems to affect lipoprotein
profiles. In a 3-year prospective study, breast-feeding women
had higher HDL-cholesterol levels than non-breast-feeding
mothers [9]. Others reported a decline in triacylglycerols after
delivery, which was more rapid in breast-feeding mothers [36].
However, at the end of the breast-feeding period, blood lipids had
again reached their baseline level [37]. We found a weak associ-
ation between breast-feeding duration and triacylglycerols as
well as with HDL-cholesterol in adult life in covariate-adjusted
linear regression models. Accounting for them in Cox models
attenuated the association of breast-feeding with diabetes.
In addition, we investigated mediating effects related to
insulin sensitivity during adulthood. Thereby we saw a posi-
tive association between cumulative breast-feeding duration
and adiponectin levels. Although we observed an attenuation
by accounting for adiponectin in our mediator analysis, others
did not find a linear association between breast-feeding dura-
tion and adiponectin levels 3 years post partum [38]. One
study found lower fasting insulin levels in breast-feeding than
non-breast-feeding women at 6 months post partum, although
there was no difference in fasting glucose levels [7]. Others
observed a trend for increased fasting insulin levels and
HOMA-IR in non-breast-feeding compared with breast-
feeding mothers [9]. Animal studies support this. During
lactation, the insulin sensitivity changes are tissue- specific
[39] as a result of alterations in signal transmission after
binding of insulin to its receptor [40]. For instance, the number
of insulin receptors of mammary epithelial cells is increased in
mice [41]. Therefore the mammary gland is more insulin-
sensitive than adipose tissue or muscle to ensure an adequate
supply of nutrients during lactation [39, 42].
The long time lag (>20 years) between the last breast-
feeding period and blood collection at the baseline examina-
tion might mask favourable effects of breast-feeding on met-
abolic variables in our analysis. However, adjustment for
biomarkers still largely attenuated the association between
breast-feeding and diabetes in our study. This suggests that
breast-feeding leads to an overall more favourable metabolic
risk profile in the long term. Previous studies discussed an
effect of breast-feeding on long-term weight development as
the main factor for decreased diabetes risk. However, our
study revealed that BMI at baseline examination only partly
explains this association.
In conclusion, the evidence from this study and previous
studies, summarised by means of meta-analysis, suggests that
longer breast-feeding duration may be related to lower mater-
nal type 2 diabetes risk. However, the role of body weight as a
mediator or confounder remains uncertain.
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